Healthcare Market Size Indonesia

1
Healthcare Spending Indonesia
2
Indonesia clinical laboratory market segment (by
type of clinical laboratory, by type of private
independent laboratory, by type of customer, by
payer, by type of test and by region),
competitive landscape of major players in
Indonesia clinical laboratory market, and
covering company profile of major clinical labs
including Prodia, Kimia Farma Diagnostika,
Pramita, Cito, BioMedika and Parahita. The report
concludes with market projection for future and
analyst recommendations highlighting the major
opportunities and cautions.
3
The healthcare market in Indonesia was majorly
impacted by the implementation of JKN (Indonesian
National Health Insurance) as the demand for
affordable/primary healthcare services,
laboratory services, and generic medicines
increased. The private independent clinical
laboratory market is dominated by organized
laboratory chains. Prodia is the market leader in
Indonesia Clinical Laboratory Market supported by
the largest labs network and experienced
management team.  
4
Indonesia Healthcare market will be facilitated
by the rising number of healthcare providers
coupled with elevating prevalence of chronic
diseases such as diabetes, HIV, Tuberculosis and
others. More than 35,000 new beds are likely to
be added in Indonesia by 2020. The clinical
laboratory market is expected to increase 1.5
times by 2022 supported by higher growth in
esoteric tests segment. The esoteric tests
segment is expected to register a high growth
during this period. The standardization of the
Coordination of Benefits (CoB) agreement between
private insurers and JKN will create
opportunities for private independent
laboratories to collaboration with private
hospitals resulting in increase in external
referrals. Private hospitals without facilities
to perform specialized or esoteric tests will be
able to refer out these tests to private
independent laboratories for those patients who
require these tests and are covered through the
CoB scheme. The major private independent
laboratories chains are expected to undergo
geographic expansion beyond key cities into
underdeveloped areas.
5
This will further lead to increase in market
share in the overall Indonesia clinical
laboratory market. For instance Prodia plans to
establish up to 33 new clinical laboratories by
2021. Further, the industry will witness a rising
trend towards precision medicine also known as
personalized medicine. Growth in the availability
of testing equipment that can be operated locally
and that does not require free-standing clinical
laboratories and advancements in self-testing
kits that can be operated by customers themselves
can result in a decrease in the volume of tests
at laboratories. Rising awareness of preventive
healthcare supported by growing disposable income
coupled with elevating prevalence of chronic and
lifestyle diseases will lead to an increase in
number of walk-in patients which will propel
Indonesia clinical laboratory market revenue in
future.
6
Ken Research in its latest study, Indonesia
Clinical Laboratory Market Outlook to 2022 - By
Type (Public Clinical Lab, Private Hospital Labs
and Private Independent Labs), By Type of Test
(Routine, Non Laboratory and Esoteric), suggests
that clinical laboratory market is expected to
reach USD 3.2 billion by 2022 growing at a CAGR
of 11.5.
7
For more information on the research report,
refer to below link https//www.kenresearch.com/h
ealthcare/diagnostics/indonesia-clinical-lab-marke
t/143543-91.html  Related Reports by Ken
Research Saudi Arabia Healthcare Market Outlook
to 2019 - Rising Lifestyle Diseases And
Government Investment To Spur Future Growth UAE
Healthcare Market Outlook to 2020 - Rising
Medical Tourism And High Prevalence Of Diabetes
To Foster Future Growth Qatar Healthcare Market
to 2021 - High Prevalence Of Diabetes And Rising
Healthcare Infrastructure To Foster Future
Growth   Contact UsKen ResearchAnkur Gupta,
Head Marketing CommunicationsAnkur_at_kenresearch.
com91-9015378249
8
(No Transcript)